|
Re: Did someone already post this?
|
2
|
Resverlogix Corp.
|
Aug 17, 2017 02:57PM
|
|
Re: What if
|
2
|
Resverlogix Corp.
|
Mar 08, 2019 10:18AM
|
|
Re: Sometimes 1 + 1 = 3
|
2
|
Resverlogix Corp.
|
Sep 24, 2016 01:45PM
|
|
BETOnMACE CHF and eGFR
|
2
|
Resverlogix Corp.
|
Mar 28, 2020 07:05PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 09:50AM
|
|
Re: Financials and MD&A on SEDAR
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 31, 2017 10:06AM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 01, 2018 09:35PM
|
|
Re: Sometimes 1 + 1 = 3
|
2
|
Resverlogix Corp.
|
Sep 24, 2016 02:25PM
|
|
Re: Zenith and Breast Cancer
|
2
|
Zenith Epigenetics
|
Mar 12, 2018 03:26PM
|
|
Re: Warrants versus Shares...
|
2
|
Resverlogix Corp.
|
Jun 26, 2017 03:25PM
|
|
Re: Did someone already post this?
|
2
|
Resverlogix Corp.
|
Aug 17, 2017 07:15PM
|
|
Re: Fiercemarkets article
|
2
|
Resverlogix Corp.
|
Mar 23, 2021 07:47PM
|
|
Re: Broker Meeting 23 Feb
|
2
|
Resverlogix Corp.
|
Mar 01, 2017 01:25PM
|
|
Re: Big Drop in Zenith today!
|
2
|
Zenith Epigenetics
|
May 05, 2023 08:20PM
|
|
Re: iceberg or ice cube?
|
2
|
Resverlogix Corp.
|
May 17, 2017 03:45PM
|
|
Pfizer starting trial for oral covid therapeutic
|
2
|
Resverlogix Corp.
|
Sep 27, 2021 11:36AM
|
|
Re: Outlook
|
2
|
Resverlogix Corp.
|
Nov 16, 2015 04:41PM
|
|
Re: Eligibility for registered accounts in Canada
|
2
|
Zenith Epigenetics
|
Aug 18, 2018 12:21PM
|
|
Re: Orphan Disease Announcement
|
2
|
Resverlogix Corp.
|
Sep 24, 2015 08:13PM
|
|
Re: Clinical Trials
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 04, 2017 07:08PM
|
